MD1804G2 - Method of prognosticating the primary open-angle glaucoma surgical treatment results - Google Patents

Method of prognosticating the primary open-angle glaucoma surgical treatment results

Info

Publication number
MD1804G2
MD1804G2 MD99-0190A MD990190A MD1804G2 MD 1804 G2 MD1804 G2 MD 1804G2 MD 990190 A MD990190 A MD 990190A MD 1804 G2 MD1804 G2 MD 1804G2
Authority
MD
Moldova
Prior art keywords
prognosticating
surgical treatment
treatment results
angle glaucoma
primary open
Prior art date
Application number
MD99-0190A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD990190A (en
MD1804F2 (en
Inventor
Константин ЖУКОВСКИЙ
Аглая ЛОБЧЕНКО
Original Assignee
Константин ЖУКОВСКИЙ
Lobcenco Aglaia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Константин ЖУКОВСКИЙ, Lobcenco Aglaia filed Critical Константин ЖУКОВСКИЙ
Priority to MD99-0190A priority Critical patent/MD1804G2/en
Publication of MD990190A publication Critical patent/MD990190A/en
Publication of MD1804F2 publication Critical patent/MD1804F2/en
Publication of MD1804G2 publication Critical patent/MD1804G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)

Abstract

The invention refers to medicine, namely to ophthalmology.Summary of the method consists in that it is carried out determination of indexes in the early postoperative period, namely the intraocular pressure (Po), the reflux coefficient (C), the Bekker coefficient (Po/C), the aqueous humor reflux resistance coefficient (R) and it is appreciated the effected operational method (MO). Afterwards, on the basis of the selected indexes there are calculated the discriminant function (F) according to formula: F=1,01´Po+8´C-0,13´Po/C+2´R+0,56´MO-21.Where F<0, it is prognosticated the favourable result, and where F³0 - the unfavourable one.
MD99-0190A 1999-07-05 1999-07-05 Method of prognosticating the primary open-angle glaucoma surgical treatment results MD1804G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD99-0190A MD1804G2 (en) 1999-07-05 1999-07-05 Method of prognosticating the primary open-angle glaucoma surgical treatment results

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD99-0190A MD1804G2 (en) 1999-07-05 1999-07-05 Method of prognosticating the primary open-angle glaucoma surgical treatment results

Publications (3)

Publication Number Publication Date
MD990190A MD990190A (en) 2001-08-31
MD1804F2 MD1804F2 (en) 2001-12-31
MD1804G2 true MD1804G2 (en) 2002-06-30

Family

ID=19739439

Family Applications (1)

Application Number Title Priority Date Filing Date
MD99-0190A MD1804G2 (en) 1999-07-05 1999-07-05 Method of prognosticating the primary open-angle glaucoma surgical treatment results

Country Status (1)

Country Link
MD (1) MD1804G2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3181G2 (en) * 2005-10-24 2007-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method of prognosticating the risk of development of nosocomial septico-purulent infections
MD3797G2 (en) * 2008-07-11 2009-08-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for estimating the result of surgical treatment of the primary open-angle glaucoma
MD3796G2 (en) * 2008-07-11 2009-09-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for estimating the result of surgical treatment of the primary open-angle glaucoma
MD434Z5 (en) * 2010-12-01 2012-06-30 Валериу КУШНИР Method of predicting the course of endogenous uveitis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Скрипка В.К. Трофический коэффициент как критерии стабилизации глаукоматозного процесса // Глаукома ( сборник трудов), Алма-Ата, 1980, с.66-71 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3181G2 (en) * 2005-10-24 2007-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method of prognosticating the risk of development of nosocomial septico-purulent infections
MD3797G2 (en) * 2008-07-11 2009-08-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for estimating the result of surgical treatment of the primary open-angle glaucoma
MD3796G2 (en) * 2008-07-11 2009-09-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for estimating the result of surgical treatment of the primary open-angle glaucoma
MD434Z5 (en) * 2010-12-01 2012-06-30 Валериу КУШНИР Method of predicting the course of endogenous uveitis

Also Published As

Publication number Publication date
MD990190A (en) 2001-08-31
MD1804F2 (en) 2001-12-31

Similar Documents

Publication Publication Date Title
WO2001041685A3 (en) Treatment of ocular disease
WO2004026347A3 (en) Apparatus and method for surgical bypass of aqueous humor
WO2002080811A3 (en) Glaucoma stent and methods thereof for glaucoma treatment
EP1224935A3 (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
WO2005105197A3 (en) Indwelling shunt device and methods for treating glaucoma
CA2353835A1 (en) Composition set and kit for use in intraocular surgery
PL396553A1 (en) Using a factor for the preparation of a medicament for the treatment of glaucoma
NO20051705L (en) Shunt device and method for the treatment of glaucoma
WO2001056567A8 (en) 2,4-diaminothiazole derivatives and their use as glycogen synthase kinase-3 (gsk-3) inhibitors
WO2001070289A3 (en) Injectable and swellable microspheres for tissue bulking
WO2003072066A3 (en) Compositions and methods for the treatment of glaucoma and ocular hypertension
ATE359794T1 (en) 3, 7 THIAPROSTANIC ACID DERIVATIVES AS AN AGENT FOR REDUCING INTERNAL EYE PRESSURE
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
WO2004043354A3 (en) Ophthalmic compositions for treating ocular hypertension
MD1804G2 (en) Method of prognosticating the primary open-angle glaucoma surgical treatment results
BR0017163A (en) 5-Hydroxyindazole Derivatives for Glaucoma Treatment
Lindquist et al. Trapezoidal astigmatic keratotomy: quantification in human cadaver eyes
WO1999038497A3 (en) Ophthalmic composition
MXPA03005922A (en) Method for treating glaucoma ib.
WO1997032593A3 (en) Composition containing iso-flavonoids and lignans
BR0215172A (en) Benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
EP1121932A4 (en) Remedies for ocular diseases
MXPA04001255A (en) Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma.
WO2002040030A8 (en) Combination therapy for lowering and controlling intraocular pressure
RU2140777C1 (en) Method of surgical treatment of glaucoma